Cholecalciferol in Chronic Dialysis Patients
Author(s) -
Bryan Kestenbaum,
Ian H. de Boer
Publication year - 2013
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.04760513
Subject(s) - medicine , vitamin d and neurology , endocrinology , vitamin d deficiency , ergocalciferol , population , bone remodeling , calcitriol receptor , cholecalciferol , secondary hyperparathyroidism , parathyroid hormone , kidney disease , cyp24a1 , calcium , environmental health
Vitamin D deficiency and insufficiency, defined by circulating concentrations of 25-hydroxyvitamin D [25(OH)D], have garnered increasing attention in clinical medicine and research. The vitamin D receptor regulates diverse biologic systems, including calcium and bone metabolism, renin-angiotensin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom